Gracell Biotechnologies
Gracell Biotechnologies
Unlock Success: Partner with CDMOs for Cell Therapy Manufacturing
📅 May 29, 2024: 🧪 Small biotech companies should engage a CDMO early for cell therapy GMP manufacturing. 📝 Documentation, quality control, and trust are key.
Unlocking the Power of Industrial IoT in Bioprocessing
📰 The Industrial Internet of Things (IIoT) is revolutionizing bioprocessing, offering better control and streamlined regulatory submissions. 💪💰
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
Bio-Techne’s CGT Boosts Growth: Q2 Success
📣 Bio-Techne Q2: CGT is a major growth driver! 🧪 Increasing demand, 💼 expanding capacity, and 💰 future growth expected.
Pfizer’s Bold Investment in Cancer Therapies
📢 Pfizer applauds its big bet in ADCs, a promising cancer treatment area, expecting long-term payoffs and therapeutic advancements. 💪🏥🩺
Revolutionizing Bioprocessing with IoT Innovation
🌐💡 The IoT can revolutionize bioprocessing by connecting devices and exchanging data, leading to more efficient experiments and automation. 🚀
Resilience Teams Up with VGXI for pDNA Supply
Resilience 📢 selects VGXI 🤝 for pDNA supply, fostering promising partnership in the 🧪 biotech industry. Resilience VGXI biotech
Dutch Biotech Firm Raises €75m to Fight Diseases
💰 Dutch biotech firm Forbion leads €75m funding for Calluna Pharma, a newly formed company targeting inflammatory and fibrotic diseases.
Major Leadership Changes in Oncology Biotechs: What’s Next?
📰 Ins & Outs: C-suite changes across oncology biotechs explores recent leadership transitions in cancer-focused biotech companies. 👥🌟🏥🧪🔬
AstraZeneca’s Big Cell Therapy Breakthrough: Gracell Acquisition
📢 AstraZeneca accelerates cell therapy ambitions through Gracell buy 🌱 Expanding capabilities, boosting oncology portfolio, and driving scientific innovation. 💪🏢🌍
